Indian Medical Experts Endorse Potassium-Enriched Salt to Combat Hypertension and Reduce Heart Attack Risk

In a significant development for cardiovascular public health, researchers from India have endorsed a novel potassium-enriched salt substitute that maintains the familiar taste of sodium chloride while substantially reducing the risk of heart attacks and strokes. This innovation addresses a critical gap in hypertension management, where excessive sodium intake remains a leading modifiable risk factor for cardiovascular disease globally, particularly in populations with high dietary salt consumption like India. The salt substitute, formulated to replace a portion of sodium chloride with potassium chloride, leverages the blood pressure-lowering effects of increased potassium intake without compromising palatability—a key barrier to adherence in low-sodium diets.

Key Clinical Takeaways:

• The potassium-enriched salt substitute reduces systolic blood pressure by approximately 4-6 mmHg in hypertensive individuals, translating to a 12-15% lower risk of major cardiovascular events.
• Large-scale trials, including the Salt Substitute and Stroke Study (SSaSS), demonstrate a 14% reduction in stroke incidence and a 12% decrease in major adverse cardiovascular events over five years of use.
• The intervention is cost-effective, safe for most adults with normal kidney function, and endorsed by Indian public health bodies as a scalable strategy to combat the nation’s hypertension epidemic affecting over 220 million adults.

The clinical rationale for potassium-enriched salt substitutes stems from the well-established pathogenesis of hypertension, wherein high sodium intake promotes fluid retention and vascular stiffness, while adequate potassium counters these effects by enhancing sodium excretion and promoting vasodilation. A landmark double-blind, placebo-controlled trial published in The New England Journal of Medicine in 2021—the SSaSS—involved over 20,000 participants with a history of stroke or uncontrolled hypertension across 600 rural villages in China. Funded by the National Health and Medical Research Council of Australia and the National Key R&D Program of China, the study found that those using the salt substitute (75% sodium chloride, 25% potassium chloride) experienced significantly lower rates of stroke, major cardiovascular events, and all-cause mortality compared to those using regular salt, with no increase in serious adverse events related to hyperkalemia in the general population.

Building on this evidence, Indian scientists at institutions including the All India Institute of Medical Sciences (AIIMS) and the Indian Council of Medical Research (ICMR) have advocated for nationwide adoption of similar formulations. A 2023 consensus statement from the Hypertension Society of India, supported by data from the India Hypertension Control Initiative (IHCI), estimates that widespread use of potassium-enriched salt could prevent approximately 300,000 cardiovascular deaths annually in India. Dr. Dorairaj Prabhakaran, Vice President of Research and Policy at the Public Health Foundation of India, emphasized the intervention’s practicality:

“Unlike behavioral dietary changes that require sustained individual effort, switching to a potassium-enriched salt substitute offers a passive, population-level strategy that works within existing culinary practices—making it uniquely suited for low-resource settings where hypertension control remains suboptimal.”

Similarly, Dr. Monika Arora, Director of Health Promotion at the Public Health Foundation of India, noted in a recent interview with The Lancet Regional Health Southeast Asia that “the taste neutrality of modern formulations is critical; if it doesn’t taste like salt, people won’t use it, no matter how strong the evidence.”

While the intervention shows promise, experts caution against use in individuals with advanced chronic kidney disease (eGFR <30 mL/min/1.73m²) or those on potassium-sparing diuretics or ACE inhibitors due to the risk of hyperkalemia—a contraindication underscored in FDA guidance on salt substitutes. Nevertheless, for the majority of hypertensive patients with preserved renal function, the benefit-risk profile strongly favors adoption. The World Health Organization recommends reducing sodium intake to less than 2 g/day (equivalent to 5 g of salt), a target unmet by over 90% of the global population; potassium-enriched salts offer a feasible pathway toward this goal without requiring drastic dietary overhauls.

From a public health perspective, integrating this innovation into national nutrition programs—such as India’s Midday Meal Scheme or public distribution system—could amplify its impact, particularly among socioeconomically vulnerable groups disproportionately affected by hypertension-related morbidity. Implementation would require coordinated efforts between food technologists, regulatory bodies like the Food Safety and Standards Authority of India (FSSAI), and healthcare providers to ensure product quality, labeling clarity, and monitoring for rare adverse events in high-risk subgroups.

For individuals managing hypertension or seeking to reduce cardiovascular risk, consulting with a healthcare provider about dietary modifications—including the potential use of evidence-based salt substitutes—is a prudent step. Those needing personalized guidance on sodium restriction, especially in the context of comorbid conditions like diabetes or chronic kidney disease, should consider reaching out to specialists through trusted channels. It is highly recommended to consult with vetted board-certified cardiologists or registered dietitians to evaluate whether a potassium-enriched salt substitute aligns with individual health profiles and treatment goals. Navigating dietary interventions within broader preventive care strategies may benefit from input from preventive medicine physicians who specialize in risk stratification and lifestyle modification.

The editorial trajectory of this research points toward broader implementation science—studying how best to scale such interventions across diverse food systems while monitoring long-term safety and equity of access. As global hypertension rates continue to rise, driven by urbanization and processed food consumption, simple, scalable innovations like potassium-enriched salt substitutes represent a vital tool in the preventive arsenal. Their success will depend not only on biological efficacy but on cultural acceptance, policy support, and integration into routine clinical and public health practice.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*